News & Opinion

» genetics & genomics and disease/medicine

Covering the life sciences inside and out

Most Recent

Two freely available databases include data on hundreds of human cancer cell lines. 

1 Comment

image: First Genetic Screen of Pigs Using ENU

First Genetic Screen of Pigs Using ENU

By | July 14, 2017

Using the mutagenic chemical N-ethyl-N-nitrosourea, researchers confirm the role of a gene in a piglet deformity and identify potential models for human diseases. 

0 Comments

image: Mini-Metagenomics Leads to Microbial Discovery

Mini-Metagenomics Leads to Microbial Discovery

By | July 14, 2017

Researchers develop a method that combines the strengths of shotgun metagenomics and single-cell genome sequencing in a microfluidics-based platform.

0 Comments

image: Anti-CRISPR Protein Reduces Off-Target Effects

Anti-CRISPR Protein Reduces Off-Target Effects

By | July 12, 2017

AcrIIA4, an inhibitor protein from the Listeria bacteriophage, can block DNA from binding to Cas9 during genome editing.

0 Comments

image: Anti-Preeclampsia Hormone Discovered

Anti-Preeclampsia Hormone Discovered

By | June 29, 2017

A small, placenta-produced peptide fixes the pregnancy-related condition in mice. 

1 Comment

An analysis of human cancer genome projects uncovers a counterintuitive loss of ribosomal gene copies.

0 Comments

The discovery of peptides, enzymes, and other gene products that confer antibiotic resistance could give clues to how it develops.

1 Comment

image: Genes Tied to Wasps Recognizing Faces

Genes Tied to Wasps Recognizing Faces

By | June 14, 2017

The brains of Polistes paper wasps express different genes when identifying faces than when distinguishing between simple patterns, a study finds.

1 Comment

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  3. Search for Life on the Red Planet
  4. Two Dozen House Republicans Do an About-Face on Tuition Tax
FreeShip